Renaissance Technologies - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,580
-54.3%
1,226,400
-29.2%
0.01%
-44.4%
Q2 2023$12,198
+6.4%
1,732,700
-7.6%
0.02%
+20.0%
Q1 2023$11,459
-44.0%
1,875,500
-41.4%
0.02%
-46.4%
Q4 2022$20,454
-99.7%
3,200,900
+295.9%
0.03%
+154.5%
Q3 2022$7,746,000
+50.3%
808,600
+199.5%
0.01%
+83.3%
Q4 2021$5,154,000
+15.8%
270,000
+92.0%
0.01%0.0%
Q1 2021$4,451,000
+298.5%
140,600
+129.0%
0.01%
+500.0%
Q3 2019$1,117,00061,4000.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 565,890$26,257,0009.39%
Consonance Capital Management LP 1,710,803$79,381,0007.41%
GREAT POINT PARTNERS LLC 917,427$42,569,0006.91%
Avoro Capital Advisors LLC 7,500,000$348,000,0005.99%
Ghost Tree Capital, LLC 500,000$23,200,0005.17%
FRAZIER MANAGEMENT LLC 1,312,999$60,923,0004.69%
Perceptive Advisors 9,166,304$425,316,0004.56%
Ally Bridge Group (NY) LLC 360,000$16,704,0002.86%
Orbimed Advisors 6,645,100$308,333,0002.70%
ACUTA CAPITAL PARTNERS, LLC 164,800$7,647,0002.08%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders